Skip to main content

JACOBS LEVY EQUITY MANAGEMENT, INC

Position in AVIR — Atea Pharmaceuticals, Inc.

CIK 884414 FLORHAM PARK, NJ

Position in AVIR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$231,899
+$78,018 QoQ
Shares Held
43,104
0.0% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in AVIR

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $231,899 43,104
2025-12-31 $153,881 43,104
2025-09-30 $1,155,426 398,423
2025-06-30 $1,045,656 290,460
2025-03-31 $353,319 118,167
2024-12-31 $1,309,511 390,899
2024-09-30 $1,706,727 509,471
2024-06-30 $1,869,812 564,898
2024-03-31 $2,718,855 672,984
2023-12-31 $1,679,137 550,537
2023-09-30 $1,660,131 553,377
2023-06-30 $2,112,247 564,772
2023-03-31 $2,117,970 632,230
2022-12-31 $2,400,468 499,058
2022-09-30 $2,165,141 380,517
2022-06-30 $3,070,309 432,438
2022-03-31 $1,109,028 153,605